Teva In $23.3-Billion Settlement Agreements in Pending Opioid Litigation
By

By
Teva Pharmaceutical and its affiliates have come to combined $23.3-billion agreements to resolve pending opioid litigation in two Ohio counties and an agreement in principle to settle remaining litigation in…

Takeda in $420 M-Deal for Celiac Disease Drug
By

By
Takeda Pharmaceutical has acquired an exclusive global license, worth up to $420 million, from Chicago-based COUR Pharmaceutical Development Company for developing and commercializing an investigational medicine for treating celiac disease.…

Sharp Clinical Expands in the UK; West Increases Stake in Daikyo Seiko
By

By
The latest news from CDMOs, CMOs, and suppliers featuring news from Sharp Clinical and West Pharmaceutical Services. Packaging Sharp Clinical Opens $12-Million Clinical Services Center of Excellence in UK Sharp…

Sartorius To Acquire Danaher Life Sciences Platform Businesses for $750 Million
By

By
As part of its pending $21.4-billion acquisition of GE’s Biopharma business, Danaher Life Sciences, a science and technology company, has agreed to sell select businesses in its life-science platform to…

Sanofi, Dr. Reddy’s, Teva Recall Ranitidine Products Due to NDMA Impurity
By

By
Several companies, Sanofi, Dr. Reddy’s Laboratories, and Teva Pharmaceutical, have initiated voluntary recalls of ranitidine products, an anti-acid, due to possible contamination with a nitrosamine impurity, N-nitrosodimethylamine (NDMA). Sanofi says…

GSK To Divest Two Vaccines to Bavarian Nordic for $1 Billion-Plus
By

By
GlaxoSmithKline (GSK) is divesting its two vaccines to Bavarian Nordic, a Kvistgaard, Denmark-based company, in a deal worth more than $1 billion.  The two vaccines being divested are Rabavert/Rabipur for…

Glenmark Spin-Off Ichnos Sciences Launches as New Biotech Company
By

By
Ichnos Sciences, a spin-off of Glenmark Holding, has launched as a new, independent biotechnology company focusing on oncology and autoimmune diseases, headquartered in Paramus, New Jersey. The company is in…

MilliporeSigma Acoustic Technology for Cell Therapy Mfg; Sekisui Invests $1.9 M in Biomfg
By

By
The latest news from CDMOs, CMOs, and suppliers featuring news from MilliporeSigma, Sekisui Diagnostics, TriPharm Services, ACG Inspection, and Bormioli Pharma. Biologics Manufacturing MilliporeSigma To Use Acoustic Technology for Cell…

FDA Issues Warning Letter to Torrent Pharmaceuticals Over Impurities in Sartan APIs
By

By
The US Food and Drug Administration (FDA) has posted a Warning Letter to Torrent Pharmaceuticals in Ahmedabad, Gujarat, India for several manufacturing violations at its facility in Taluka-Kadi, Indrad, Gujarat,…

Takeda To Divest Select OTC and Rx Products in Emerging Markets for $200 Million-Plus
By

By
Takeda Pharmaceutical has agreed to divest to Acino, a Zurich-based pharmaceutical company, a portfolio of select over-the-counter (OTC) and prescription pharmaceutical assets in a number of countries in the Near…